A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology
Candice A. Roufosse, Naomi Simmonds, Marian C. Clahsen‐van Groningen et al. · Transplantation · 2018
The Banff Classification of Allograft Pathology is an international consensus classification for the reporting of biopsies from solid organ transplants. Since its initial conception in 1991 for renal transplants, it has undergone review every 2 years, with attendant updated publications. The rapid expansion of knowledge in the field has led to numerous revisions of the classification. The resultant dispersal of relevant content makes it difficult for novices and experienced pathologists to faithfully apply the classification in routine diagnostic work and in clinical trials. This review shall provide a complete and simple illustrated reference guide of the Banff Classification of Kidney Allograft Pathology based on all publications including the 2017 update. It is intended as a concise desktop reference for pathologists and clinicians, providing definitions, Banff Lesion Scores and Banff Diagnostic Categories. An online website reference guide hosted by the Banff Foundation for Allograft Pathology (www.banfffoundation.org) is being developed, which will be updated with future refinement of the Banff Classification from 2019 onward.
Cited by 771 works. doi:10.1097/tp.0000000000002366
Authors
- Candice A. Roufosse
- Naomi Simmonds
- Marian C. Clahsen‐van Groningen
- Mark Haas
- Kammi Henriksen
- Catherine J. Horsfield
- Alexandre Loupy
- Michael Mengel
- Agnieszka Perkowska‐Ptasińska
- Marion Rabant
- Lorraine C. Racusen
- Kim Solez
- Jan Ulrich Becker
References
- The Banff 97 working classification of renal allograft pathology
- International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
- Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
- The Human Cell Atlas
- The Human Cell Atlas
- Banff ’05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (’CAN’)
- Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
- The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
- Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
- The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology